| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 20.16B | 19.27B | 22.62B | 33.97B | 22.15B | 15.35B |
| Gross Profit | 7.78B | 7.70B | 7.51B | 6.77B | 5.62B | 5.01B |
| EBITDA | 4.70B | 5.22B | 5.19B | 4.63B | 3.74B | 2.02B |
| Net Income | 2.00B | 1.90B | 1.99B | 1.65B | 1.21B | -55.00M |
Balance Sheet | ||||||
| Total Assets | 36.51B | 40.84B | 37.89B | 40.39B | 38.25B | 39.55B |
| Cash, Cash Equivalents and Short-Term Investments | 3.25B | 6.10B | 4.12B | 4.39B | 4.36B | 4.49B |
| Total Debt | 16.91B | 18.01B | 15.96B | 16.26B | 16.69B | 17.35B |
| Total Liabilities | 26.75B | 29.18B | 25.96B | 30.41B | 29.38B | 28.28B |
| Stockholders Equity | 7.78B | 9.48B | 9.45B | 7.57B | 5.89B | 8.03B |
Cash Flow | ||||||
| Free Cash Flow | 2.41B | 1.79B | 2.43B | 2.16B | -203.00M | 1.96B |
| Operating Cash Flow | 4.63B | 3.99B | 4.86B | 2.16B | 1.00B | 3.43B |
| Investing Cash Flow | -2.11B | -1.82B | -2.74B | 1.16B | 1.90B | -1.14B |
| Financing Cash Flow | -3.26B | -239.00M | -2.26B | -2.54B | -2.85B | -388.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | €7.94B | 10.62 | 13.06% | 1.80% | 2.05% | 307.60% | |
72 Outperform | €23.25B | 12.74 | 22.84% | 6.43% | 2.66% | 1.26% | |
69 Neutral | €31.12B | 14.54 | 26.86% | 4.51% | -4.53% | 221.40% | |
67 Neutral | €112.71B | 20.93 | 10.92% | 3.12% | -1.89% | -21.48% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
64 Neutral | €9.08B | 24.69 | 10.14% | 3.88% | -23.15% | -39.13% | |
55 Neutral | €3.63B | 26.82 | 3.85% | 7.05% | 5.35% | ― |